Critical appraisal of lurasidone in the management of schizophrenia
Silvio Caccia, Luca Pasina, Alessandro NobiliIstituto di Ricerche Farmacologiche, “Mario Negri”, Milan, ItalyAbstract: Lurasidone is a new atypical antipsychotic in the benzoisothiazoles class of chemicals. Like most second-generation antipsychotics it is a full antagonis...
Guardado en:
Autores principales: | Caccia S, Pasina L, Nobili A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/96d715a4b74646e18bf4a8fb4ce307f5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The clinical utility of lurasidone in schizophrenia: patient considerations
por: Harvey PD
Publicado: (2015) -
Lurasidone as a potential therapy for bipolar disorder
por: Woo YS, et al.
Publicado: (2013) -
Lurasidone for the treatment of bipolar depression: an evidence-based review
por: Franklin R, et al.
Publicado: (2015) -
New and extended-action treatments in the management of ADHD: a critical appraisal of lisdexamfetamine in adults and children
por: Diana Domnitei, et al.
Publicado: (2010) -
Critical appraisal of the role of fingolimod in the treatment of multiple sclerosis
por: Warnke C, et al.
Publicado: (2011)